Peer-reviewed clinical study shows Thoraguard® delivers effective, automated chest tube drainage following cardiac surgery
Omaha, NE, July 26, 2022 — Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University Medical Center, published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the first and only digital chest tube management system that provides automated clog clearance without human intervention while continuously and precisely monitoring critical physiological parameters to inform clinical decision-making and optimize outcomes.
The study found that Thoraguard is safe and effective compared to conventional analog chest tubes when used following cardiac surgery (the study’s primary endpoints). The authors noted that the Thoraguard…